Delivery Order FA486121D0004-FA486123F0082
Award Date
3/16/23
Potential Completion Date
3/15/24
Potential Value
$125K
Federal Agency
Air Combat Command
Awardee
Genomic Health, Inc.
Ultimate Awardee
Exact Sciences Corporation
NAICS Category
621511 - Medical Laboratories
PSC Category
Q999 - Medical- Other
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
North Las Vegas, NV 89030, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, to provide Oncotype DX cancer testing services to the U.S. Air Force's Air Combat Command. The delivery order is valued at $124,588.79 and has a period of performance from March 16, 2024 to March 15, 2025, with a total contract period extending to March 2025. Genomic Health has been awarded multiple prime federal contracts and task orders from agencies such as the Department of Veterans...
Genomic Health, Inc., a subsidiary of Exact Sciences Corp, has been awarded a $141,858.59 firm fixed price delivery order contract by the Department of the Air Force Air Combat Command. The contract calls for Genomic Health to provide Oncotype DX cancer testing services to support the agency's medical programs. Performance will take place in Las Vegas, Nevada. No set-aside provisions were applied to this award. Genomic Health will leverage its subsidiary Exact Sciences Laboratories to fulfill...
This is a firm fixed-price delivery order awarded by the Air Education and Training Command, a defense agency, to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation. The contract, valued at $3,453.96, is for the provision of Oncotype DX Pathology Tests, which are advanced genomic cancer diagnostic services. This order is placed under the Medical Laboratory Testing and Analysis Services contract vehicle, a General Services Administration (GSA) schedule. Genomic Health provides these...
This is a Definitive Contract awarded by the Defense Health Agency to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for Oncotype DX cancer testing services. The $642,816.16 firm fixed-price contract covers the provision of these specialized genomic diagnostic services to various military and veterans' healthcare facilities, including Travis Air Force Base, from January 1, 2020 to March 31, 2025. Genomic Health, Inc. has significant federal Indefinite Delivery Vehicle (IDV)...
The Department of the Air Force Materiel Command awarded a $41,186.49 firm fixed price call against a blanket purchase agreement to Genomic Health, Inc. for medical products or services. Performance will occur in Wright-Patterson, Ohio. Genomic Health is a subsidiary of Exact Sciences Corp, which will perform the work through its Exact Sciences Laboratories division under the Exact brand name. No set aside provisions were included. This contract provides the Air Force Materiel Command with...
This is a firm fixed-price purchase order awarded by the Air Education and Training Command (AETC), a defense agency, to Genomic Health, Inc. for pathology testing services. The contract has a ceiling value of $3,453.96 and a completion date of October 12, 2018. Genomic Health, Inc. is a subsidiary of Exact Sciences Corporation that specializes in providing advanced genetic testing services, particularly for cancer screening, treatment selection, and disease monitoring. The company has a...
The Department of the Air Force Materiel Command awarded a $48,094.41 firm fixed price call against a blanket purchase agreement to Genomic Health, Inc. for medical products or services. Performance will occur in Wright-Patterson, Ohio. Genomic Health is a subsidiary of Exact Sciences Corp, which will perform the work through its Exact Sciences Laboratories division. No small business set-aside designation was used for this contract to deliver unspecified medical requirements to the Air Force...
The Defense Health Agency awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for cancer testing services. The potential value of the contract is $124,081.53, with a completion date of September 30, 2019. Genomic Health has provided cancer testing services, including its Oncotype DX portfolio of assays, to the Department of Defense and Department of Veterans Affairs under past federal contracts. This award is...
This federal contract award is for the Oncotype DX laboratory test, which was awarded to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation. The contract, awarded by the Department of the Army Medical Command, has a potential value of $250,000.00 and is a firm fixed price purchase order with no set-aside designation. Genomic Health has a history of federal contracts to provide cancer testing services, including its Oncotype DX portfolio, to the Defense Health Agency, Department...
This award is for a purchase order of $78,364.30 to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, to provide breast cancer testing services to the Defense Health Agency. The contract has a firm fixed price pricing type and a completion date of September 30, 2016. Genomic Health is a for-profit organization that specializes in providing genomic cancer testing services to the federal government, including the Department of Veterans Affairs, Department of Defense, Air Force,...